Marrone Bio Innovations Stock Forecast, Price & News

Marrone Bio Innovations (NASDAQ:MBII) Frequently Asked Questions

Is Marrone Bio Innovations a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marrone Bio Innovations in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Marrone Bio Innovations stock.
View analyst ratings for Marrone Bio Innovations or view top-rated stocks.

How has Marrone Bio Innovations' stock price been impacted by Coronavirus?

Marrone Bio Innovations' stock was trading at $0.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MBII stock has decreased by 15.3% and is now trading at $0.7287.
View which stocks have been most impacted by COVID-19.

When is Marrone Bio Innovations' next earnings date?

Marrone Bio Innovations is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022.
View our earnings forecast for Marrone Bio Innovations.

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations, Inc. (NASDAQ:MBII) announced its quarterly earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) earnings per share for the quarter, meeting the Zacks' consensus estimate of ($0.03). The basic materials company had revenue of $9.86 million for the quarter, compared to the consensus estimate of $10.79 million. Marrone Bio Innovations had a negative net margin of 37.49% and a negative trailing twelve-month return on equity of 46.77%. During the same period last year, the business posted ($0.04) EPS.
View Marrone Bio Innovations' earnings history.

What price target have analysts set for MBII?

5 brokerages have issued 1 year target prices for Marrone Bio Innovations' stock. Their forecasts range from $2.00 to $4.00. On average, they expect Marrone Bio Innovations' share price to reach $2.90 in the next twelve months. This suggests a possible upside of 298.0% from the stock's current price.
View analysts' price targets for Marrone Bio Innovations or view top-rated stocks among Wall Street analysts.

Who are Marrone Bio Innovations' key executives?

Marrone Bio Innovations' management team includes the following people:

• Kevin R. Helash, Chief Executive Officer & Director
• Sue Cheung, Chief Financial Officer
• Amit Vasavada, Chief Technology Officer, Senior VP-R&D
• Linda V. Moore, Secretary, Chief Compliance Officer & EVP
• Keith J. Pitts, Chief Sustainability Officer & Senior VP

Who are some of Marrone Bio Innovations' key competitors?

Some companies that are related to Marrone Bio Innovations include American Vanguard (AVD), Wynnstay Group (WYN), AgroFresh Solutions (AGFS), Calyxt (CLXT), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), Evogene (EVGN), Eden Research (EDEN), Save Foods (SVFD), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), China Agri-Business (CHBU), Igene Biotechnology (IGNE) and Nufarm (NUF).
View all of MBII's competitors.

What other stocks do shareholders of Marrone Bio Innovations own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marrone Bio Innovations investors own include Ekso Bionics (EKSO), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), KushCo (KSHB), Enerplus (ERF), ADMA Biologics (ADMA), Great Panther Mining (GPL), OrganiGram (OGI), 22nd Century Group (XXII) and Aeterna Zentaris (AEZS).

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

Who are Marrone Bio Innovations' major shareholders?

Marrone Bio Innovations' stock is owned by many different institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (9.59%), BlackRock Inc. (2.77%), Geode Capital Management LLC (0.97%), Primecap Management Co. CA (0.96%), Uniplan Investment Counsel Inc. (0.70%) and Allianz Asset Management GmbH (0.64%). Company insiders that own Marrone Bio Innovations stock include Pamela G Marrone and Pamela G Marrone.
View institutional ownership trends for Marrone Bio Innovations.

Which institutional investors are selling Marrone Bio Innovations stock?

MBII stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Allianz Asset Management GmbH, Primecap Management Co. CA, Deutsche Bank AG, Two Sigma Investments LP, California State Teachers Retirement System, UBS Group AG, and Geode Capital Management LLC.
View insider buying and selling activity for Marrone Bio Innovations or view top insider-selling stocks.

Which institutional investors are buying Marrone Bio Innovations stock?

MBII stock was purchased by a variety of institutional investors in the last quarter, including Uniplan Investment Counsel Inc., Renaissance Technologies LLC, Vident Investment Advisory LLC, Morgan Stanley, SG Americas Securities LLC, Barclays PLC, Bank of New York Mellon Corp, and IndexIQ Advisors LLC.
View insider buying and selling activity for Marrone Bio Innovations or or view top insider-buying stocks.

How do I buy shares of Marrone Bio Innovations?

Shares of MBII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marrone Bio Innovations' stock price today?

One share of MBII stock can currently be purchased for approximately $0.73.

How much money does Marrone Bio Innovations make?

Marrone Bio Innovations has a market capitalization of $129.09 million and generates $38.37 million in revenue each year. The basic materials company earns $-20.17 million in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does Marrone Bio Innovations have?

Marrone Bio Innovations employs 145 workers across the globe.

What is Marrone Bio Innovations' official website?

The official website for Marrone Bio Innovations is www.marronebioinnovations.com.

Where are Marrone Bio Innovations' headquarters?

Marrone Bio Innovations is headquartered at 1540 Drew Avenue, Davis CA, 95618.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Avenue, Davis CA, 95618. The basic materials company can be reached via phone at (530) 750-2800 or via email at [email protected].